Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Otsuka Holdings (4578 JP): All Eyes on Sibeprenlimab in Likely Stable 2026, More Approvals Awaited

Otsuka Holdings (4578 JP): Rexulti, Abilify Gain Further Traction in 1Q26, Guidance Reiterated

Otsuka Holdings (4578 JP): Voyxact Positive Trial Data Augur Well For the Future

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/otsuka-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:12292:1" rel="noopener">Otsuka Holdings (4578 JP)</a> announced strong 1H26 result, with all key parameters being ahead of guidance. Business profit achieving progress rate of 162% against 1H26 forecast was the key highlight.</li>
<li>Reflecting strong 1H26 performance, the company has raised 2026 revenue guidance by ¥205B or 8% to ¥2,725B and business profit guidance by ¥115B or 32% to ¥470B.</li>
<li>Otsuka is entering a new phase of growth, where its existing businesses continue to deliver stable performance while next-generation growth drivers are beginning to take shape.</li>
</ul>



Otsuka Holdings (4578 JP) announced strong 1H26 result, with all key parameters being ahead of guidance. Business profit achieving progress rate of 162% against 1H26 forecast was the key highlight.
Reflecting strong 1H26 performance, the company has raised 2026 revenue guidance by ¥205B or 8% to ¥2,725B and business profit guidance by ¥115B or 32% to ¥470B.
Otsuka is entering a new phase of growth, where its existing businesses continue to deliver stable performance while next-generation growth drivers are beginning to take shape.


Otsuka Holdings (4578 JP): Strong 1H Result; FY Guidance Revision; Approaching Next Level Growth